PMID: 9547499Apr 21, 1998Paper

A gradient inverse planning algorithm with dose-volume constraints

Medical Physics
S V Spirou, C S Chui

Abstract

An inverse planning algorithm for determining the intensity-modulated beams that will most closely generate a desired dose distribution is presented. The algorithm is three-dimensional and does not explicitly depend on beam energies and modalities. It allows a single prescription dose or a window of acceptable doses to be specified for the target, with additional constraints to account for under- or over-dosing. For the protection of organs at risk, it provides maximum-dose and dose-volume constraints. The latter apply to the entire volume of the organ exposed to the corresponding dose levels. Several levels of each type of constraint, with varying penalty weights, may be specified for each organ. The objective function that serves as the measure of the goodness of the solution is of the least-squares type and is minimized using conjugate gradient methods. Typical clinical cases involving 40,000 points and 4000 rays to be determined require about 10 min of CPU time on a DEC AlphaStation. Results are presented for two clinical sites, prostate and lung. The optimization algorithm yielded plans that featured higher target dose homogeneity, compared with the human planner's plan, while selectively sparing more of the normal organs ...Continue Reading

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·A Niemierko
Oct 1, 1991·Physics in Medicine and Biology·S M MorrillI I Rosen
Nov 1, 1991·Medical Physics·S M MorillI I Rosen
Aug 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·R BoeseckeW J Lorenz
May 15, 1991·International Journal of Radiation Oncology, Biology, Physics·B EmamiM Wesson
Mar 1, 1991·Medical Physics·I I RosenJ A Belli
Sep 1, 1990·Medical Physics·A Niemierko, M Goitein
Oct 1, 1990·Physics in Medicine and Biology·T BortfeldW Schlegel
Apr 1, 1990·International Journal of Radiation Oncology, Biology, Physics·M LangerJ Shapiro
Jul 1, 1990·International Journal of Radiation Oncology, Biology, Physics·S M MorrillJ A Belli
May 1, 1986·Medical Physics·C S Chui, R Mohan
Aug 1, 1987·International Journal of Radiation Oncology, Biology, Physics·M Langer, J Leong
Jun 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M OldhamS Webb
Jul 15, 1995·International Journal of Radiation Oncology, Biology, Physics·T W HolmesP Reckwerdt
Aug 30, 1995·International Journal of Radiation Oncology, Biology, Physics·S Söderström, A Brahme
Jan 1, 1994·Physics in Medicine and Biology·R SvenssonA Brahme
Sep 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·R MohanC C Ling
Feb 15, 1995·International Journal of Radiation Oncology, Biology, Physics·A JacksonT S Lawrence
Aug 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J SteinW Schlegel
Mar 1, 1994·Medical Physics·A GustafssonA Brahme
Nov 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·X H WangC C Ling
Jun 1, 1996·Medical Physics·M LangerO Lee
Mar 1, 1996·Medical Physics·X WangB Mohan

❮ Previous
Next ❯

Citations

Jan 11, 2012·Health Care Management Science·Delal DinkBehlul Saka
Apr 6, 2004·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·N AillèresJ B Dubois
Apr 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Suzanne L WoldenPaul A Meyers
Jun 7, 2005·International Journal of Radiation Oncology, Biology, Physics·Cesar Della BianciaJoachim Yahalom
Jun 1, 2005·International Journal of Radiation Oncology, Biology, Physics·Fernando F de ArrudaNancy Y Lee
Dec 20, 2003·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Maria F ChanC Clifton Ling
Jun 28, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·L XingA L Boyer
Jul 6, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M EssersB J Heijmen
Feb 1, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Anna Samuelsson, Karl-Axel Johansson
Mar 22, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Daniela CorlettoClaudio Fiorino
May 14, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Anna SamuelssonKarl-Axel Johansson
Feb 5, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J G LiL Xing
Jun 6, 2000·International Journal of Radiation Oncology, Biology, Physics·C C LingJ A Koutcher
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·M A HuntS A Leibel
Nov 13, 2001·International Journal of Radiation Oncology, Biology, Physics·UNKNOWN Intensity Modulated Radiation Therapy Collaborative Working Group
Jan 5, 2002·International Journal of Radiation Oncology, Biology, Physics·Qiuwen WuRupert Schmidt-Ullrich
Jun 14, 2002·International Journal of Radiation Oncology, Biology, Physics·Ching-Yeh HsiungHoward I Amols
Aug 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Linda HongSteve Leibel
Oct 16, 2002·International Journal of Radiation Oncology, Biology, Physics·Margie A HuntClifton C Ling
Feb 8, 2003·International Journal of Radiation Oncology, Biology, Physics·Kamil M YeniceHoward I Amols
Feb 8, 2003·International Journal of Radiation Oncology, Biology, Physics·Kolby SidhuHoward Amols
Apr 16, 2003·International Journal of Radiation Oncology, Biology, Physics·Michael K M KamPeter M L Teo
Jun 6, 2003·International Journal of Radiation Oncology, Biology, Physics·Evert Woudstra, Ben J M Heijmen
Jul 23, 2003·International Journal of Radiation Oncology, Biology, Physics·K S Clifford ChaoJames F Dempsey
Oct 8, 2003·International Journal of Radiation Oncology, Biology, Physics·Jining ZhouQiuwen Wu
Oct 25, 2003·International Journal of Radiation Oncology, Biology, Physics·Thomas H WagnerSanford L Meeks
Jul 27, 1999·International Journal of Radiation Oncology, Biology, Physics·L HongB McCormick
Jul 11, 2001·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·U Oelfke, T Bortfeld
Jul 11, 2001·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·C S Chui, S V Spirou
Nov 11, 2008·Physics in Medicine and Biology·Renzhi LuAndrew Jackson
Jan 15, 2010·Physics in Medicine and Biology·Hao H ZhangWarren D D'Souza
Jul 31, 2002·Zeitschrift für medizinische Physik·Ludwig Bogner
Oct 14, 2009·American Journal of Clinical Oncology·Abraham J WuNancy Y Lee
Dec 24, 2005·Medical Physics·Richard A PoppleIvan A Brezovich
Jun 30, 2005·Medical Physics·Qiuwen WuYan Wu
Jul 23, 2011·Medical Physics·Hans StabenauAndrew Jackson
Feb 10, 2011·Medical Physics·R VaitheeswaranVikram Maiya
Feb 26, 2008·Medical Physics·Shuang LuanCedric X Yu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.